PD-1

You have access
Implications of PD-1, Tim-3, and TIGIT Expression for Cancer Immunity and Pancreatic Cancer Prognosis
CHIERI NAKAYAMA, KIYONORI TANOUE, TETSUYA IDICHI, HIROKI SHIMOMURA, YOSHIAKI KITA, YUTO HOZAKA, YOSHIAKI SHINDEN, DAISUKE MATSUSHITA, AKIHIRO NAKAJO, TAKAAKI ARIGAMI, YUKO MATAKI, HIROSHI KURAHARA and TAKAO OHTSUKA

Anticancer Research July 2022, 42 (7) 3373-3380; DOI: https://doi.org/10.21873/anticanres.15824
Open Access
Programmed Cell Death Ligand-1 (PDL-1) Correlates With Tumor Infiltration by Immune Cells and Represents a Promising Target for Immunotherapy in Endometrial Cancer
THOMAS HECKING, THORE THIESLER, JANINA HALBE, LUCIA OTTEN, FLORIAN RECKER, HEIDRUN GEVENSLEBEN, TIM MÜLLER, CYNTHIA SCHILLER, EVA K. EGGER, ROLF FIMMERS, MATTHIAS B. STOPE, GLEN KRISTIANSEN and ALEXANDER MUSTEA

Anticancer Research March 2022, 42 (3) 1367-1376; DOI: https://doi.org/10.21873/anticanres.15606
You have access
The Expression of Immune Checkpoint Receptors and Ligands in the Colorectal Cancer Tumor Microenvironment
PRAJWAL NEUPANE, KOSAKU MIMURA, SHOTARO NAKAJIMA, HIROKAZU OKAYAMA, MISATO ITO, AUNG KYI THAR MIN, KATSUHARU SAITO, HISASHI ONOZAWA, SHOTARO FUJITA, WATARU SAKAMOTO, MOTONOBU SAITO, ZENICHIRO SAZE, TOMOYUKI MOMMA and KOJI KONO

Anticancer Research October 2021, 41 (10) 4895-4905; DOI: https://doi.org/10.21873/anticanres.15303
You have access
Recovery of the Sensitivity to Anti-PD-1 Antibody by Celecoxib in Lung Cancer
KUNIHIKO KOBAYASHI, KYOICHI KAIRA and HIROSHI KAGAMU

Anticancer Research September 2020, 40 (9) 5309-5311; DOI: https://doi.org/10.21873/anticanres.14537
You have access
Mutant KRAS Promotes NKG2D⁺ T Cell Infiltration and CD155 Dependent Immune Evasion
KENSUKE NISHI, SHUHEI ISHIKURA, MASAYO UMEBAYASHI, TAKASHI MORISAKI, TAKASHI INOZUME, TETSUSHI KINUGASA, MIKIKO AOKI, SATOSHI NIMURA, ANTHONY SWAIN, YOICHIRO YOSHIDA, SUGURU HASEGAWA, KAZUKI NABESHIMA, TOSHIFUMI SAKATA, SENJI SHIRASAWA and TOSHIYUKI TSUNODA

Anticancer Research August 2020, 40 (8) 4663-4674; DOI: https://doi.org/10.21873/anticanres.14465
You have access
Association Between Formalin Fixation Time and Programmed Cell Death Ligand 1 Expression in Patients With Non-Small Cell Lung Cancer
HAYATO KAWACHI, DAICHI FUJIMOTO, DAISUKE YAMASHITA, JUNYA FUKUOKA, YUKA KITAMURA, KAZUTAKA HOSOYA, YUKI SATO, KAZUMA NAGATA, ATSUSHI NAKAGAWA, RYO TACHIKAWA, NAOKI DATE, ICHIRO SAKANOUE, HIROSHI HAMAKAWA, YUTAKA TAKAHASHI and KEISUKE TOMII

Anticancer Research May 2019, 39 (5) 2561-2567; DOI: https://doi.org/10.21873/anticanres.13378
You have access
Comparison of PD-L1 Assays in Non-small Cell Lung Cancer: 22C3 pharmDx and SP263
DAICHI FUJIMOTO, DAISUKE YAMASHITA, JUNYA FUKUOKA, YUKA KITAMURA, KAZUTAKA HOSOYA, HAYATO KAWACHI, YUKI SATO, KAZUMA NAGATA, ATSUSHI NAKAGAWA, RYO TACHIKAWA, NAOKI DATE, ICHIRO SAKANOUE, HIROSHI HAMAKAWA, YUTAKA TAKAHASHI and KEISUKE TOMII

Anticancer Research December 2018, 38 (12) 6891-6895; DOI: https://doi.org/10.21873/anticanres.13065
You have access
PD-1 and PD-L1 Up-regulation Promotes T-cell Apoptosis in Gastric Adenocarcinoma
YING-MING CHIU, CHUNG-LIN TSAI, JUNG-TA KAO, CHIN-TUNG HSIEH, DONG-CHEN SHIEH, YI-JU LEE, GREGORY J. TSAY, KEN-SHENG CHENG and YI-YING WU

Anticancer Research April 2018, 38 (4) 2069-2078;
You have access
Highly Activated PD-1/PD-L1 Pathway in Gastric Cancer with PD-L1 Expression
HIROAKI SAITO, YUSUKE KONO, YUKI MURAKAMI, YUJI SHISHIDO, HIROHIKO KURODA, TOMOYUKI MATSUNAGA, YOJI FUKUMOTO, TOMOHIRO OSAKI, KEIGO ASHIDA and YOSHIYUKI FUJIWARA

Anticancer Research January 2018, 38 (1) 107-112;
You have access
Comparison of PD-L1 mRNA Expression Measured with the CheckPoint Typer® Assay with PD-L1 Protein Expression Assessed with Immunohistochemistry in Non-small Cell Lung Cancer
RAMONA ERBER, ROBERT STÖHR, STEFANIE HERLEIN, CLAUDIA GIEDL, RALF JOACHIM RIEKER, FLORIAN FUCHS, JOACHIM H. FICKER, ARNDT HARTMANN, ELKE VELTRUP, RALPH M. WIRTZ and WOLFGANG M. BRUECKL

Anticancer Research December 2017, 37 (12) 6771-6778;

Main menu

User menu

Search

PD-1

Pages